Centene Reports Quarterly Loss Amid Rising Costs
On Friday, Centene announced an unexpected quarterly loss, disappointing investors who have already faced multiple setbacks as expenses for government-backed insurance plans continue to rise. In response, the company’s shares plummeted 14.5% in pre-market trading, negatively impacting peers like eLlevance and Molina Healthcare, which also signaled concerns over increasing costs related to government-supported insurance.
The insurance sector has been under pressure for the past two years, primarily due to escalating healthcare expenses. Insurance companies are trying to enhance the utilization of behavioral health services, home care, and high-cost medications, but the expiration of pandemic-era subsidies and Medicaid protections has subsumed registries with less healthy members, compressing profit margins.
Focusing on government-sponsored plans, Centene reported a medical care ratio (MCR) of 93% this quarter, well above Wall Street’s expectation of 89.3%, suggesting significant strain across various business lines. Morningstar analyst Julie Attterback pointed out, “While healthcare costs this quarter were surprisingly high and seemed related to all major business lines, their individual exchange businesses were probably the biggest culprit.”
The quarterly loss mainly stems from anticipated downward adjustments in risk-adjusted revenues for 2025, a component of the affordable care methodology that aims to balance expenses among insurers. This adjustment, alongside increased Medicaid spending, led to an adjusted loss of $0.86 per share, a stark contrast to a second-quarter adjusted loss of $0.16 per share, according to compiled data.
CEO Sarah London expressed disappointment regarding the second-quarter results but acknowledged the trends influencing performance and the need to restore revenue streams. Centene plans to share revenue forecasts for 2025 during an upcoming conference call.
Furthermore, the company is pushing for a premium increase in its 2026 Affordable Care Act plan, aligned with a growing ratio of patients requiring more intensive medical care. Centene anticipates that the majority of states with significant membership in these plans will implement necessary pricing adjustments for 2026.
